Shenzhen Ausa Pharmed Co.,Ltd
Quick facts
Marketed products
- Amlodipine besylate and folic acid · Cardiovascular
Amlodipine besylate blocks L-type calcium channels to reduce blood pressure, while folic acid is a B vitamin that supports cellular methylation and DNA synthesis. - Amlodipine-folic acid placebos · Cardiovascular
Amlodipine blocks L-type calcium channels to reduce blood pressure, while folic acid supplementation supports cardiovascular and metabolic health. - Amlodipine placebos · Cardiovascular
Amlodipine is a calcium channel blocker that relaxes blood vessels and reduces heart workload to lower blood pressure. - Enalapril/folic acid · Cardiovascular
Enalapril inhibits angiotensin-converting enzyme (ACE) to reduce blood pressure, while folic acid supplementation supports cardiovascular health and may reduce homocysteine levels. - Enalapril maleate and folic acid tablets · Cardiovascular
Enalapril inhibits angiotensin-converting enzyme (ACE) to reduce blood pressure, while folic acid supplementation supports cellular methylation and DNA synthesis.
Phase 2 pipeline
- Amlodipine-FA tablet,high dose group · Cardiovascular
Amlodipine-FA tablet works by inhibiting the L-type calcium channels in smooth muscle cells, leading to vasodilation and reduced blood pressure. - Amlodipine-FA tablet,low dose group · Cardiovascular
Amlodipine-FA is a calcium channel blocker that works by relaxing blood vessels and reducing blood pressure.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: